170 related articles for article (PubMed ID: 17549667)
1. Basic helix-loop-helix transcription factor profiling of lung tumors shows aberrant expression of the proneural gene atonal homolog 1 (ATOH1, HATH1, MATH1) in neuroendocrine tumors.
Westerman BA; Breuer RH; Poutsma A; Chhatta A; Noorduyn LA; Koolen MG; Postmus PE; Blankenstein MA; Oudejans CB
Int J Biol Markers; 2007; 22(2):114-23. PubMed ID: 17549667
[TBL] [Abstract][Full Text] [Related]
2. Quantitative reverse transcription-polymerase chain reaction measurement of HASH1 (ASCL1), a marker for small cell lung carcinomas with neuroendocrine features.
Westerman BA; Neijenhuis S; Poutsma A; Steenbergen RD; Breuer RH; Egging M; van Wijk IJ; Oudejans CB
Clin Cancer Res; 2002 Apr; 8(4):1082-6. PubMed ID: 11948117
[TBL] [Abstract][Full Text] [Related]
3. [Expression and clinicopathologic significance of human achaete-scute homolog 1 in pulmonary neuroendocrine tumors].
Li F; Zhong Z; Li R; Huang H; Wang L; Zheng D; Zhang D
Zhongguo Fei Ai Za Zhi; 2010 Apr; 13(4):317-21. PubMed ID: 20677557
[TBL] [Abstract][Full Text] [Related]
4. EGFR mediates activation of RET in lung adenocarcinoma with neuroendocrine differentiation characterized by ASCL1 expression.
Bhinge K; Yang L; Terra S; Nasir A; Muppa P; Aubry MC; Yi J; Janaki N; Kovtun IV; Murphy SJ; Halling G; Rahi H; Mansfield A; de Andrade M; Yang P; Vasmatzis G; Peikert T; Kosari F
Oncotarget; 2017 Apr; 8(16):27155-27165. PubMed ID: 28460442
[TBL] [Abstract][Full Text] [Related]
5. Achaete-scute homolog 1 as a marker of poorly differentiated neuroendocrine carcinomas of different sites: a validation study using immunohistochemistry and quantitative real-time polymerase chain reaction on 335 cases.
La Rosa S; Marando A; Gatti G; Rapa I; Volante M; Papotti M; Sessa F; Capella C
Hum Pathol; 2013 Jul; 44(7):1391-9. PubMed ID: 23375646
[TBL] [Abstract][Full Text] [Related]
6. Application of Small Cell Lung Cancer Molecular Subtyping Markers to Small Cell Neuroendocrine Carcinoma of the Cervix: NEUROD1 as a Poor Prognostic Factor.
Kim G; Kim M; Nam EJ; Lee JY; Park E
Am J Surg Pathol; 2024 Mar; 48(3):364-372. PubMed ID: 37981832
[TBL] [Abstract][Full Text] [Related]
7. Insights into the achaete-scute homolog-1 gene (hASH1) in normal and neoplastic human lung.
Miki M; Ball DW; Linnoila RI
Lung Cancer; 2012 Jan; 75(1):58-65. PubMed ID: 21684625
[TBL] [Abstract][Full Text] [Related]
8. Hypermethylation of adjacent CpG sites is negatively correlated with the expression of lineage oncogene ASCL1 in pulmonary neuroendocrine tumors.
Truong N; Chun SM; Kim TI; Suh YA; Jang SJ
Tumour Biol; 2017 Jun; 39(6):1010428317706225. PubMed ID: 28621224
[TBL] [Abstract][Full Text] [Related]
9. ASCL1-coexpression profiling but not single gene expression profiling defines lung adenocarcinomas of neuroendocrine nature with poor prognosis.
Fujiwara T; Hiramatsu M; Isagawa T; Ninomiya H; Inamura K; Ishikawa S; Ushijima M; Matsuura M; Jones MH; Shimane M; Nomura H; Ishikawa Y; Aburatani H
Lung Cancer; 2012 Jan; 75(1):119-25. PubMed ID: 21737174
[TBL] [Abstract][Full Text] [Related]
10. hASH1 expression is closely correlated with endocrine phenotype and differentiation extent in pulmonary neuroendocrine tumors.
Jiang SX; Kameya T; Asamura H; Umezawa A; Sato Y; Shinada J; Kawakubo Y; Igarashi T; Nagai K; Okayasu I
Mod Pathol; 2004 Feb; 17(2):222-9. PubMed ID: 14657947
[TBL] [Abstract][Full Text] [Related]
11. Aberrant expression of human achaete-scute homologue gene 1 in the gastrointestinal neuroendocrine carcinomas.
Shida T; Furuya M; Nikaido T; Kishimoto T; Koda K; Oda K; Nakatani Y; Miyazaki M; Ishikura H
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):450-8. PubMed ID: 15701827
[TBL] [Abstract][Full Text] [Related]
12. Significance of achaete-scute complex homologue 1 (ASCL1) in pulmonary neuroendocrine carcinomas; RNA sequence analyses using small cell lung cancer cells and Ascl1-induced pulmonary neuroendocrine carcinoma cells.
Kudoh S; Tenjin Y; Kameyama H; Ichimura T; Yamada T; Matsuo A; Kudo N; Sato Y; Ito T
Histochem Cell Biol; 2020 Jun; 153(6):443-456. PubMed ID: 32170367
[TBL] [Abstract][Full Text] [Related]
13. Identification of a human achaete-scute homolog highly expressed in neuroendocrine tumors.
Ball DW; Azzoli CG; Baylin SB; Chi D; Dou S; Donis-Keller H; Cumaraswamy A; Borges M; Nelkin BD
Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5648-52. PubMed ID: 8390674
[TBL] [Abstract][Full Text] [Related]
14. Conservation of the Drosophila lateral inhibition pathway in human lung cancer: a hairy-related protein (HES-1) directly represses achaete-scute homolog-1 expression.
Chen H; Thiagalingam A; Chopra H; Borges MW; Feder JN; Nelkin BD; Baylin SB; Ball DW
Proc Natl Acad Sci U S A; 1997 May; 94(10):5355-60. PubMed ID: 9144241
[TBL] [Abstract][Full Text] [Related]
15. Achaete-scute complex homologue 1 regulates tumor-initiating capacity in human small cell lung cancer.
Jiang T; Collins BJ; Jin N; Watkins DN; Brock MV; Matsui W; Nelkin BD; Ball DW
Cancer Res; 2009 Feb; 69(3):845-54. PubMed ID: 19176379
[TBL] [Abstract][Full Text] [Related]
16. Proneural and proneuroendocrine transcription factor expression in cutaneous mechanoreceptor (Merkel) cells and Merkel cell carcinoma.
Leonard JH; Cook AL; Van Gele M; Boyle GM; Inglis KJ; Speleman F; Sturm RA
Int J Cancer; 2002 Sep; 101(2):103-10. PubMed ID: 12209986
[TBL] [Abstract][Full Text] [Related]
17. NOTCH, ASCL1, p53 and RB alterations define an alternative pathway driving neuroendocrine and small cell lung carcinomas.
Meder L; König K; Ozretić L; Schultheis AM; Ueckeroth F; Ade CP; Albus K; Boehm D; Rommerscheidt-Fuss U; Florin A; Buhl T; Hartmann W; Wolf J; Merkelbach-Bruse S; Eilers M; Perner S; Heukamp LC; Buettner R
Int J Cancer; 2016 Feb; 138(4):927-38. PubMed ID: 26340530
[TBL] [Abstract][Full Text] [Related]
18. Atonal homolog 1 is a tumor suppressor gene.
Bossuyt W; Kazanjian A; De Geest N; Van Kelst S; De Hertogh G; Geboes K; Boivin GP; Luciani J; Fuks F; Chuah M; VandenDriessche T; Marynen P; Cools J; Shroyer NF; Hassan BA
PLoS Biol; 2009 Feb; 7(2):e39. PubMed ID: 19243219
[TBL] [Abstract][Full Text] [Related]
19. Differences of molecular expression mechanisms among neural cell adhesion molecule 1, synaptophysin, and chromogranin A in lung cancer cells.
Kashiwagi K; Ishii J; Sakaeda M; Arimasu Y; Shimoyamada H; Sato H; Miyata C; Kamma H; Aoki I; Yazawa T
Pathol Int; 2012 Apr; 62(4):232-45. PubMed ID: 22449227
[TBL] [Abstract][Full Text] [Related]
20. The balance between the expressions of hASH1 and HES1 differs between large cell neuroendocrine carcinoma and small cell carcinoma of the lung.
Nasgashio R; Sato Y; Matsumoto T; Kageyama T; Hattori M; Iyoda A; Satoh Y; Ryuge S; Masuda N; Jiang SX; Saegusa M
Lung Cancer; 2011 Dec; 74(3):405-10. PubMed ID: 21601304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
